Acute Blood Loss
Acute blood loss stresses oxygen delivery and circulatory stability. Early lab signals reveal falling red cell mass before symptoms escalate. At Superpower, we test Hemoglobin, Hematocrit, and RBC to quantify oxygen-carrying capacity and intravascular volume shifts, distinguishing true hemorrhage from dilutional changes and guiding timely clinical assessment.
Alcoholic Liver Disease
Alcoholic Liver Disease disrupts hepatocyte function, bile flow, and protein synthesis. Biomarker testing clarifies injury and reserve. At Superpower, we test for AST, ALT, GGT, Bilirubin, and Albumin to track hepatocellular damage, cholestasis, and synthetic capacity—helping map liver system health before complications.
COVID-19 Severe
Biomarker testing helps detect dangerous immune overactivation in severe COVID-19. At Superpower, we test NLR, CRP, and ferritin for COVID-19 Severe. These measures capture inflammation, immune cell shifts, and iron dysregulation (neutrophil-to-lymphocyte ratio, C-reactive protein, ferritin), enabling objective risk stratification and trajectory monitoring.
Celiac Disease
Celiac disease damages intestinal villi, impairing nutrient absorption and provoking systemic inflammation. Biomarker testing helps reveal these effects early. At Superpower, we assess Hemoglobin and Ferritin for anemia, Folate and B12 for malabsorption, and ESR for inflammatory activity—together mapping gastrointestinal integrity and whole-body impacts.
Cholestasis
Cholestasis signals reduced bile flow, stressing the liver and biliary system and allowing bile salts and bilirubin to build up (hepatobiliary dysfunction). Targeted biomarkers detect this early. At Superpower, we test ALP, GGT, Bilirubin Direct, and BAR for Cholestasis to map cholestatic patterns and differentiate intrahepatic from obstructive causes.
Chronic Infection
Chronic infection strains immune and inflammatory systems. Biomarkers reveal persistent activation and tissue stress. At Superpower, we track ESR and CRP for ongoing inflammation, WBC for immune cell response, and SII (Systemic Immune-Inflammation Index) to integrate counts, clarifying chronic immune load and recovery trajectory.
Chronic Infection (Hep B/C/HIV/TB)
Chronic infections strain the immune system and drive persistent inflammation, affecting multiple organs. Biomarker testing tracks this biology. At Superpower, we measure CRP and ESR (systemic inflammatory response) and WBC count (immune cell activity) to flag ongoing inflammatory load and immunologic stress in Hepatitis B/C, HIV, and TB.
Cirrhosis
Cirrhosis disrupts liver architecture and function, affecting protein synthesis, detoxification, and portal blood flow. Biomarker testing tracks this physiology in real time. At Superpower, we measure Albumin, Total Protein, Bilirubin, Platelets, and AST/ALT to assess synthetic capacity, cholestasis, portal hypertension risk, and hepatocellular injury.
HIV/AIDS Advanced
Advanced HIV biomarker testing clarifies immune system strength and infection control. Tracking lymphocyte levels shows how well your defenses are working and whether HIV is suppressing immunity. At Superpower, we test Lymphocytes and Absolute Lymphocytes to quantify immune cell counts (total lymphocyte count), guiding disease staging and monitoring.
Hepatitis
Biomarker testing clarifies liver inflammation and function in suspected hepatitis. It distinguishes hepatocellular injury from cholestasis and impaired protein synthesis. At Superpower, we measure ALT and AST (cell injury), Bilirubin (bile processing), and Albumin (synthetic capacity) to map liver system health and detect silent disease before complications.
SIRS
SIRS reflects a body-wide inflammatory response that can signal infection, trauma, or systemic stress. Timely biomarkers clarify immune activation and severity. At Superpower, we test WBC, neutrophils, CRP, NLR, PLR, and SIRI to map inflammatory load, immune balance, and risk of complications.
Sepsis
Sepsis is a life‑threatening immune overreaction to infection. Biomarkers reveal the body’s inflammatory and immune balance in real time, guiding urgency and risk. At Superpower, we measure white blood cells (WBC), neutrophils, C‑reactive protein (CRP), neutrophil‑to‑lymphocyte ratio (NLR), and the systemic immune‑inflammation index (SII) for sepsis.
